Sanofi

This study is checking the safety of a high-dose flu vaccine called Efluelda Tetra in adults aged 65 and older in South Korea. About 670 participants will receive one dose and be monitored for side effects for about a month. The goal is to see how often reactions occur during rou…

This study is checking the safety of a high-dose flu vaccine (Efluelda) in adults aged 65 and older in South Korea. About 670 participants will receive one shot and be monitored for side effects over about a month. The goal is to confirm the vaccine is safe when used in everyday …

This study tests a new drug called itepekimab in Japanese adults with chronic sinusitis and nasal polyps that are not well controlled by standard treatments. The goal is to see if the drug can shrink polyps and improve nasal congestion over 52 weeks. About 20 participants will re…

This study tests the safety of a drug called belumosudil in 26 Indian patients aged 12 and older who have chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. Participants must have tried at least two prior treatments. The study lasts up to 12 m…

This study looks at the long-term safety of a drug called balinatunfib in adults with Crohn's disease or ulcerative colitis. Participants have already completed a one-year study with the drug or a placebo. The goal is to see if the drug is safe over a longer period, up to about t…